Edition:
United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

23.45USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$23.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
858,487
52-wk High
$33.00
52-wk Low
$13.60

Panem, Sandra 

Dr. Sandra Panem, Ph.D., is an Independent Director of Acorda Therapeutics, Inc. She is currently a partner at Cross Atlantic Partners, which she joined in 2000. She is also currently President of NeuroNetworks Fund, a not-for-profit venture capital fund focusing on neurodisorders which she co-founded in December 2014. From 1994 to 1999, Dr. Panem was President of Vector Fund Management, the then asset management affiliate of Vector Securities International. Prior thereto, Dr. Panem served as Vice President and Portfolio Manager for the Oppenheimer Global BioTech Fund, a mutual fund that invested in public and private biotechnology companies. Previously, she was Vice President at Salomon Brothers Venture Capital, a fund focused on early and later-stage life sciences and technology investments. Dr. Panem was also a Science and Public Policy Fellow in economic studies at the Brookings Institution, and an Assistant Professor of Pathology at the University of Chicago. She received a B.S. in biochemistry and a Ph.D. in microbiology from the University of Chicago. Dr. Panem currently serves on the boards of directors of Labcyte, Inc. and BioLineRx Ltd.

Basic Compensation

Total Annual Compensation, USD 77,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 178,766
Fiscal Year Total, USD 255,766

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

3,433,220

Richard Batycky

--

David Lawrence

1,360,800

Andrew Blight

1,484,560

Jane Wasman

1,986,540

Burkhard Blank

3,521,550
As Of  30 Dec 2016